We are monitoring the impact of COVID-19 on Cartilage Regeneration Market Get in touch with us for detailed analysis Know More
Share on

Global Cartilage Regeneration Market (Cartilage Repair Market) Size, Share, Trends & Growth Analysis Report – Segmented By Type Of Treatment, Application & Region - Industry Forecast (2022 to 2027)

Published: January, 2022
ID: 2508
Pages: 175

Global Cartilage Regeneration Market (2022 to 2027)

As per our analysis, the size of the global cartilage regeneration market is estimated to value USD 1219.3 million by 2027 from USD 627.77 million in 2022, growing at a CAGR of 14.2% during the forecast period.

The primary function of cartilage is to connect bones. It does so by its elasticity to bend a bit but, at the same time, resisting stretching. It is found in many parts of the body, such as joints, ribcages, nose, ear, throat, and backbones. However, the amplest type of cartilage found in the human body is the hyaline cartilage, which is seen as supportive tissue in the ears, nose, and throat (trachea, smaller respiratory tubes, larynx). Cartilage tissue is vital because of the flexibility and stability of movement it provides.

MARKET DRIVERS:

The primary factors driving the growth of the global cartilage regeneration market are the rapidly rising incidence of osteoarthritis, increasing research funding and investments, rapidly rising obesity amongst the population, growing joint and bone disorders among people, advancements in cartilage regeneration, the cost-effectiveness of chondrocyte transplantation. In addition, over the forecast period, an increase in the frequency of traffic accidents and sports-related injuries resulting in bone and joint injuries is expected to fuel demand for cartilage regeneration products. The growing number of cartilage regeneration products being developed reflects the sector's growing interest and technological advancements. Basic research advances in cartilage repair led to improved therapeutic therapies, but their effectiveness is dependent on their capacity to simplify surgical procedures and increase tissue regeneration.

The global market for cartilage regeneration is further projected to be driven by the growing prevalence of bone, stem cell-based tissue engineering, and joint diseases and technical improvements in cartilage regeneration in the coming years. In addition, the market is expected to increase in the next few years as the elderly population grows and the incidence of sports injuries rises. Furthermore, during the forecasted period, the rising incidence of diabetes is expected to boost the cartilage regeneration market.

MARKET RESTRAINTS:

The high cost of cartilage repair operations is estimated to restrict the growth of the global cartilage regeneration market. There are a lot of restrictions and obstacles that might stymie cartilage regeneration market expansion. The cartilage regeneration industry is likely to be challenged by a lack of cartilage-based stem cell products. A few constraints are expected to include unfavorable reimbursement scenarios and increasing therapeutic costs.

Impact of COVID-19 on the global cartilage regeneration market:

COVID-19 is an unprecedented worldwide public health crisis that has impacted nearly every business. The long-term repercussions are expected to influence industry growth throughout the forecast period. During the first half of the forecast period, the COVID-19 outbreak will influence the cartilage regeneration market. The cartilage regeneration market is anticipated to drop during the first phase of the forecasted period due to countrywide lockdowns, denied wound care services, and canceled or postponed elective procedures. In addition, patients cannot access hospitals, outpatient clinics, or clinics due to the lockdowns. During the forecasted period, this temporary denial of wound care services, cancer care surgeries/therapies, and other healthcare services are likely to hinder the growth of the cartilage regeneration market. However, during the second phase of the pandemic, it regains its growth and is likely to continue in the future.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2021 to 2027

Base Year

2021

Forecast Period

2022 to 2027

Segments Covered

By Type of treatment, application, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

Zimmer Biomet Holdings, Inc. (U.S.), Vericel Corporation (U.S.), Smith & Nephew plc (U.K.), Osiris Therapeutics, Inc. (U.S.), and Arthrex Inc. (U.S.).

 

This market research report on the global cartilage regeneration market has been segmented and sub-segmented based on the type of treatment, application, and region.

Cartilage Regeneration Market – By Type of Treatment:

  • Cell-Based Approaches
    • Stem Cells
    • Growth Factor Technology
    • Chondrocyte Transplantation
  • Non-Cell-Based Approaches
    • Cell-Free Composites
    • Tissue Scaffolds

Based on the type of treatment, the cell-based approach segment of the global cartilage regeneration market held the highest share of the treatment modality segment. Technology developments in stem cell-based treatments for cartilage repair and chondrocyte implantation products are responsible for a substantial part of this market. As a result, the cell-based category led the market, and it is anticipated to increase at a healthy rate over the next several years. It is also expected to expand due to the rising demand for autologous chondrocyte transplants for surgical treatment of damaged articular cartilage (chondral and osteochondral lesions).

In the Non-Cell-Based Approaches segment, Tissue scaffolds and cell-free composites are two types of non-cell-based materials. The tissue scaffold segment has the largest share after the cell-based approach segment. When transplanted into the knees and other joints, tissue scaffolds can encourage cartilage and bone development; thus, they are utilized more frequently than cell-free composites.

Cartilage Regeneration Market – By Application:

  • Hyaline Cartilage Regeneration
  • Fibrocartilage Regeneration

Based on the application, because of the growing incidences of physical trauma throughout the world, which can induce osteochondral and chondral lesions in patients, the Hyaline cartilage regeneration segment is expected to dominate this market over the forecast period. Furthermore, due to the high sensitivity of hyaline cartilage to damage in the event of cartilage-related accidents, the hyaline segment is likewise predicted to develop at the quickest rate throughout the projection period. Furthermore, an increase in sports-related injuries leads to articular cartilage abnormalities in the knee and other joints, which is expected to promote sector growth.

Cartilage Regeneration Market – By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Geographically, North America leads the global market, accounting for the significant global market share and expanding with the highest CAGR during the forecast period. North America’s lead is warranted by the presence of a high number of registered patients and increasing the use of cartilage repair or regeneration to treat sports injuries and other accidents. Due to the increased incidence of bone and joint diseases, an increase in the number of accidents and injuries, and the expanding population in the area, North America is anticipated to lead the cartilage regeneration market over the forecast period. Furthermore, rising physician and patient awareness of newly developed treatment methods and technologies, as well as significant government investments in the technologies and therapies used in Cartilage Repair/Regeneration, are all contributing to the market's rise in North America. Furthermore, because of the rising incidence of musculoskeletal disorders, target populations, and changing lifestyles of persons in the United States and Canada, North America represented the largest market in 2020.

The European market comes in second in terms of market share due to rising awareness about blood-related disorders and the swift availability of treatment in plasma fractionation.

However, Asia-Pacific is expected to catch up fast during the forecast period because of a vast population base once the costs of cartilage regeneration come down with growth in R&D and technology. Furthermore, the cartilage regeneration market in the Asia Pacific is expected to expand at the fastest CAGR during the forecast period, owing to the growing elderly population and the resulting rise in the prevalence of different diseases and injuries. In addition, recent advancements in tissue engineering and stem cell treatment are expected to boost market growth even further.

Over the forecast period, the cartilage repair market is likely to be governed by the growing incidence of diabetes and obesity worldwide. Diabetes leads to a greater loss of cartilage. Furthermore, throughout the forecast period, global growth in the obese (overweight) population, primarily in Latin America and the Middle East Africa region, is projected to boost demand for cartilage repair products.

KEY MARKET PLAYERS:

A few of the noteworthy companies operating in the global cartilage regeneration market profiled in this report are Zimmer Biomet Holdings, Inc. (U.S.), Vericel Corporation (U.S.), Smith & Nephew plc (U.K.), Osiris Therapeutics, Inc. (U.S.), and Arthrex Inc. (U.S.).

RECENT MARKET DEVELOPMENTS:

  • Smith & Nephew purchased Osiris Therapeutics, Inc. in 2019. (US). Smith & Nephew advanced wound care management sector was strengthened due to this purchase, which extended the company's client base.
  • To speed up CARTISTEM production, MEDIPOST (South Korea) expanded its GMP manufacturing facility in 2019.
  • Innovative Cellular Therapeutics (ICT, China) and Vericel Corporation partnered in 2018 to develop and distribute MACI, Epicel, Ixmyelocel-T, and Carticel medicines in China, South Korea, Singapore, and other Asian markets.
  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
        1. Secondary Research
        2. Primary Research
        3. Econometric Modelling
        4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. By Type of Treatment
      1. Cell Based Approaches
        1. Stem Cells
        2. Growth Factor Technology
        3. Chondrocyte Transplantation
      2. Non- Cell Based Approaches
        1. Cell Free Composites
        2. Tissue Scaffolds
      3. Y-o-Y Growth Analysis, By Type of Treatment                                                                                                                                                                        
      4. Market Attractiveness Analysis, By Type of Treatment                                                                                                                                                                      
      5. Market Share Analysis, By Type of Treatment      
    2. By Application
      1. Introduction                                                                                                                                                                           
      2. Hyaline Cartilage Regeneration                                                                                                                                                                      
      3. Fibrocartilage Regeneration                                                                                                                                                                            
      4. Y-o-Y Growth Analysis, By Application                                                                                                                                                                         
      5. Market Attractiveness Analysis, By Application                                                                                                                                                                       
      6. Market Share Analysis, By Application           
  6. Geographical Analysis
    1. Introduction    
      1. Regional Trends   
      2. Impact Analysis    
      3. Y-o-Y Growth Analysis        
        1. By Geographical Area
        2. By Material Type
        3. By Form
      4. Market Attractiveness Analysis      
        1. By Geographical Area
        2. By Material Type
        3. By Form
      5.      Market Share Analysis   
        1. By Geographical Area
        2. By Material Type
        3. By Form
    2. North America
      1. Introduction
      2. US
      3. Canada
    3. Europe
      1. Introduction
      2. UK
      3. France
      4. Spain
      5. Germany
      6. Italy
    4. Asia-Pacific
      1. Introduction
      2. India
      3. China
      4. Japan
      5. South Korea
      6. Australia
    5. Latin America
      1. Introduction
      2. Brazil
      3. Argentina
      4. Mexico
    6. Middle East & Africa
      1. Introduction
      2. Middle East
      3. Africa
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. Zimmer Biomet Holdings, Inc. (U.S.)
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Vericel Corporation (U.S.)
    3. Smith & Nephew plc (U.K.)
    4. Osiris Therapeutics, Inc. (U.S.)
    5. Arthrex Inc. (U.S.)
  9. Competitive Landscape
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations and Joint Ventures
    4. New Product Launches
  10. Market Outlook and Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures  
  1. Global Cartilage Regeneration Market, By Region, From 2022 - 2027 (USD Billion)
  2. Global Cartilage Regeneration Market, By Type of Treatment, From 2022 - 2027 (USD Billion)
  3. Global Cell Based Approaches Market, By Region, From 2022 - 2027 (USD Billion)
  4. Global Stem Cells Market, By Region, From 2022 - 2027 (USD Billion)
  5. Global Growth Factor Technology Market, By Region, From 2022 - 2027 (USD Billion)
  6. Global Chondrocyte Transplantation Market, By Region, From 2022 - 2027 (USD Billion)
  7. Global Non-Cell Based Approaches Market, By Region, From 2022 - 2027 (USD Billion)
  8. Global Cell Free Composites Market, By Region, From 2022 - 2027 (USD Billion)
  9. Global Tissue Scaffolds Market, By Region, From 2022 - 2027 (USD Billion)
  10. Global Cartilage Regeneration Market, By Application, From 2022 - 2027 (USD Billion)
  11. Global Hyaline Cartilage Regeneration Market, By Region, From 2022 - 2027 (USD Billion)
  12. Global Fibrocartilage Regeneration Market, By Region, From 2022 - 2027 (USD Billion)
  13. North America Cartilage Regeneration Market, By Type of Treatment, From 2022 - 2027 (USD Billion)
  14. North America Cell Based Approaches Market, By Region, From 2022 - 2027 (USD Billion)
  15. North America Stem Cells Market, By Region, From 2022 - 2027 (USD Billion)
  16. North America Growth Factor Technology Market, By Region, From 2022 - 2027 (USD Billion)
  17. North America Chondrocyte Transplantation Market, By Region, From 2022 - 2027 (USD Billion)
  18. North America Non-Cell Based Approaches Market, By Region, From 2022 - 2027 (USD Billion)
  19. North America Cell Free Composites Market, By Region, From 2022 - 2027 (USD Billion)
  20. North America Tissue Scaffolds Market, By Region, From 2022 - 2027 (USD Billion)
  21. North America Cartilage Regeneration Market, By Application, From 2022 - 2027 (USD Billion)
  22. North America Hyaline Cartilage Regeneration Market, By Region, From 2022 - 2027 (USD Billion)
  23. North America Fibrocartilage Regeneration Market, By Region, From 2022 - 2027 (USD Billion)
  24. United States Cartilage Regeneration Market, By Type of Treatment, From 2022 - 2027 (USD Billion)
  25. United States Cartilage Regeneration Market, By Application, From 2022 - 2027 (USD Billion)
  26. Canada Cartilage Regeneration Market, By Type of Treatment, From 2022 - 2027 (USD Billion)
  27. Canada Cartilage Regeneration Market, By Application, From 2022 - 2027 (USD Billion)
  28. Europe Cartilage Regeneration Market, By Type of Treatment, From 2022 - 2027 (USD Billion)
  29. Europe Cell Based Approaches Market, By Region, From 2022 - 2027 (USD Billion)
  30. Europe Stem Cells Market, By Region, From 2022 - 2027 (USD Billion)
  31. Europe Growth Factor Technology Market, By Region, From 2022 - 2027 (USD Billion)
  32. Europe Chondrocyte Transplantation Market, By Region, From 2022 - 2027 (USD Billion)
  33. Europe Non-Cell Based Approaches Market, By Region, From 2022 - 2027 (USD Billion)
  34. Europe Cell Free Composites Market, By Region, From 2022 - 2027 (USD Billion)
  35. Europe Tissue Scaffolds Market, By Region, From 2022 - 2027 (USD Billion)
  36. Europe Cartilage Regeneration Market, By Application, From 2022 - 2027 (USD Billion)
  37. Europe Hyaline Cartilage Regeneration Market, By Region, From 2022 - 2027 (USD Billion)
  38. Europe Fibrocartilage Regeneration Market, By Region, From 2022 - 2027 (USD Billion)
  39. U.K. Cartilage Regeneration Market, By Type of Treatment, From 2022 - 2027 (USD Billion)
  40. U.K. Cartilage Regeneration Market, By Application, From 2022 - 2027 (USD Billion)
  41. Germany Cartilage Regeneration Market, By Type of Treatment, From 2022 - 2027 (USD Billion)
  42. Germany Cartilage Regeneration Market, By Application, From 2022 - 2027 (USD Billion)
  43. France Cartilage Regeneration Market, By Type of Treatment, From 2022 - 2027 (USD Billion)
  44. France Cartilage Regeneration Market, By Application, From 2022 - 2027 (USD Billion)
  45. Italy Cartilage Regeneration Market, By Type of Treatment, From 2022 - 2027 (USD Billion)
  46. Italy Cartilage Regeneration Market, By Application, From 2022 - 2027 (USD Billion)
  47. Spain Cartilage Regeneration Market, By Type of Treatment, From 2022 - 2027 (USD Billion)
  48. Spain Cartilage Regeneration Market, By Application, From 2022 - 2027 (USD Billion)
  49. Asia-Pacific Cartilage Regeneration Market, By Type of Treatment, From 2022 - 2027 (USD Billion)
  50. Asia-Pacific Cell Based Approaches Market, By Region, From 2022 - 2027 (USD Billion)
  51. Asia-Pacific Stem Cells Market, By Region, From 2022 - 2027 (USD Billion)
  52. Asia-Pacific Growth Factor Technology Market, By Region, From 2022 - 2027 (USD Billion)
  53. Asia-Pacific Chondrocyte Transplantation Market, By Region, From 2022 - 2027 (USD Billion)
  54. Asia-Pacific Non-Cell Based Approaches Market, By Region, From 2022 - 2027 (USD Billion)
  55. Asia-Pacific Cell Free Composites Market, By Region, From 2022 - 2027 (USD Billion)
  56. Asia-Pacific Tissue Scaffolds Market, By Region, From 2022 - 2027 (USD Billion)
  57. Asia-Pacific Cartilage Regeneration Market, By Application, From 2022 - 2027 (USD Billion)
  58. Asia-Pacific Hyaline Cartilage Regeneration Market, By Region, From 2022 - 2027 (USD Billion)
  59. Asia-Pacific Fibrocartilage Regeneration Market, By Region, From 2022 - 2027 (USD Billion)
  60. Japan Cartilage Regeneration Market, By Type of Treatment, From 2022 - 2027 (USD Billion)
  61. Japan Cartilage Regeneration Market, By Application, From 2022 - 2027 (USD Billion)
  62. China Cartilage Regeneration Market, By Type of Treatment, From 2022 - 2027 (USD Billion)
  63. China Cartilage Regeneration Market, By Application, From 2022 - 2027 (USD Billion)
  64. India Cartilage Regeneration Market, By Type of Treatment, From 2022 - 2027 (USD Billion)
  65. India Cartilage Regeneration Market, By Application, From 2022 - 2027 (USD Billion)
  66. Australia Cartilage Regeneration Market, By Type of Treatment, From 2022 - 2027 (USD Billion)
  67. Australia Cartilage Regeneration Market, By Application, From 2022 - 2027 (USD Billion)
  68. South Korea Cartilage Regeneration Market, By Type of Treatment, From 2022 - 2027 (USD Billion)
  69. South Korea Cartilage Regeneration Market, By Application, From 2022 - 2027 (USD Billion)
  70. Latin America Cartilage Regeneration Market, By Type of Treatment, From 2022 - 2027 (USD Billion)
  71. Latin America Cell Based Approaches Market, By Region, From 2022 - 2027 (USD Billion)
  72. Latin America Stem Cells Market, By Region, From 2022 - 2027 (USD Billion)
  73. Latin America Growth Factor Technology Market, By Region, From 2022 - 2027 (USD Billion)
  74. Latin America Chondrocyte Transplantation Market, By Region, From 2022 - 2027 (USD Billion)
  75. Latin America Non-Cell Based Approaches Market, By Region, From 2022 - 2027 (USD Billion)
  76. Latin America Cell Free Composites Market, By Region, From 2022 - 2027 (USD Billion)
  77. Latin America Tissue Scaffolds Market, By Region, From 2022 - 2027 (USD Billion)
  78. Latin America Cartilage Regeneration Market, By Application, From 2022 - 2027 (USD Billion)
  79. Latin America Hyaline Cartilage Regeneration Market, By Region, From 2022 - 2027 (USD Billion)
  80. Latin America Fibrocartilage Regeneration Market, By Region, From 2022 - 2027 (USD Billion)
  81. Brazil Cartilage Regeneration Market, By Type of Treatment, From 2022 - 2027 (USD Billion)
  82. Brazil Cartilage Regeneration Market, By Application, From 2022 - 2027 (USD Billion)
  83. Argentina Cartilage Regeneration Market, By Type of Treatment, From 2022 - 2027 (USD Billion)
  84. Argentina Cartilage Regeneration Market, By Application, From 2022 - 2027 (USD Billion)
  85. Mexico Cartilage Regeneration Market, By Type of Treatment, From 2022 - 2027 (USD Billion)
  86. Mexico Cartilage Regeneration Market, By Application, From 2022 - 2027 (USD Billion)
  87. Rest of Latin America Cartilage Regeneration Market, By Type of Treatment, From 2022 - 2027 (USD Billion)
  88. Rest of Latin America Cartilage Regeneration Market, By Application, From 2022 - 2027 (USD Billion)
  89. Middle East & Africa Cartilage Regeneration Market, By Type of Treatment, From 2022 - 2027 (USD Billion)
  90. Middle East & Africa Cell Based Approaches Market, By Region, From 2022 - 2027 (USD Billion)
  91. Middle East & Africa Stem Cells Market, By Region, From 2022 - 2027 (USD Billion)
  92. Middle East & Africa Growth Factor Technology Market, By Region, From 2022 - 2027 (USD Billion)
  93. Middle East & Africa Chondrocyte Transplantation Market, By Region, From 2022 - 2027 (USD Billion)
  94. Middle East & Africa Non-Cell Based Approaches Market, By Region, From 2022 - 2027 (USD Billion)
  95. Middle East & Africa Cell Free Composites Market, By Region, From 2022 - 2027 (USD Billion)
  96. Middle East & Africa Tissue Scaffolds Market, By Region, From 2022 - 2027 (USD Billion)
  97. Middle East & Africa Cartilage Regeneration Market, By Application, From 2022 - 2027 (USD Billion)
  98. Middle East & Africa Hyaline Cartilage Regeneration Market, By Region, From 2022 - 2027 (USD Billion)
  99. Middle East & Africa Fibrocartilage Regeneration Market, By Region, From 2022 - 2027 (USD Billion)
  100. Middle East Cartilage Regeneration Market, By Type of Treatment, From 2022 - 2027 (USD Billion)
  101. Middle East Cartilage Regeneration Market, By Application, From 2022 - 2027 (USD Billion)
  102. Africa Cartilage Regeneration Market, By Type of Treatment, From 2022 - 2027 (USD Billion)
  103. Africa Cartilage Regeneration Market, By Application, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

4255


pdf excel
$

5060


pdf excel powerbi
$

7360


excel
$

2500

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 4255

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample